Adtalem Global Education (NYSE:CVSA) Insider Karen Sue Cox Sells 2,000 Shares

Adtalem Global Education Inc. (NYSE:CVSA) insider Karen Sue Cox sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $124.50, for a total transaction of $249,000.00. Following the sale, the insider directly owned 31,596 shares of the company’s stock, valued at approximately $3,933,702. This trade represents a 5.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Stock Performance

Shares of CVSA stock traded down $1.96 during trading hours on Tuesday, hitting $128.28. 239,676 shares of the company were exchanged, compared to its average volume of 392,864. The stock has a market capitalization of $4.37 billion, a price-to-earnings ratio of 19.98, a P/E/G ratio of 1.11 and a beta of 0.63. Adtalem Global Education Inc. has a fifty-two week low of $86.97 and a fifty-two week high of $156.26. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70. The company’s 50 day simple moving average is $111.84.

Adtalem Global Education (NYSE:CVSA) last announced its quarterly earnings data on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping the consensus estimate of $1.73 by $0.25. The company had revenue of $487.03 million during the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same period last year, the business earned $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, sell-side analysts expect that Adtalem Global Education Inc. will post 8.05 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have commented on CVSA. Barrington Research reissued an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a research note on Friday, April 17th. Truist Financial raised their price objective on Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday. Zacks Research cut Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Weiss Ratings began coverage on Adtalem Global Education in a research note on Wednesday, February 25th. They issued a “hold (c+)” rating for the company. Finally, Wall Street Zen cut Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.